Got $1,000? 5 Stocks to Buy Now While They're on Sale.

This is less a broad “consumer is cheap” setup than a dispersion trade between names with real self-help and names that just have multiple support. AMZN’s near-term signal is demand elasticity, but the investable edge is margin leverage from automation and AI in fulfillment/AWS; if contribution margins expand in the next 1-2 quarters, the stock can re-rate, but a promo-heavy quarter would tell you the event was mostly pull-forward rather than true demand strength.

BABA is the cleaner 6-18 month asymmetric expression: cash-rich balance sheet, improving cloud monetization, and AI validation can justify multiple expansion if China stabilizes. The consensus is underweighting how quickly China internet names can rerate on even modest policy calm; the main falsifier is renewed regulatory/geopolitical pressure, which can overwhelm fundamentals in days. ELF is more of a distribution/M&A story than a pure cosmetics call: Rhode raises the mix toward higher-margin prestige, and that can pressure slower-turn beauty brands and force ULTA/TGT to prioritize viral labels over incumbents.

CAVA and JAKK are growth-through-scarcity names, but both are vulnerable to impatience. CAVA can work over years if unit economics hold, yet any slowdown in traffic as expansion accelerates would compress the premium multiple quickly; JAKK’s zero-debt balance sheet is a cushion, but tariffs and licensing normalization are the swing factors over the next 1-3 quarters. The market may be too eager to buy “consumer on sale” as a basket; the better expression is owning self-help and avoiding stories that still need perfect execution.